About the Menopause: Case studies webcast

This webinar is designed to be a practical and interactive guide on the management of complex menopause cases in General Practice. The session will be presented by Dr Carmel Reynolds, GP and Dr Sonia Davison, Endocrinologist who both have high level expertise in the management of menopause. Dr Elina Safro, Chair of the AMS Education Subcommittee will be moderating the session. Cases to be presented include patients with migraine, venous thromboembolism and breast cancer risk. Participants are also invited to submit their own cases for discussion. The session will be followed with 30-minutes of Q&A.

Speakers

Dr Carmel Reynolds MBBS, DCH FRACGP Cert Family Planning

Dr Reynolds is the SA/NT representative AMS Board Member. She is a GP with a strong interest in Women’s Health generally but specifically in contraception sexual health, menopause, and perinatal health. Carmel has worked in rural, regional and metropolitan practices in Western Australia and in inner city Adelaide.

Carmel is a member of the Adelaide Pelvic Pain Network, a multidisciplinary team developed to help care for people with persistent Pelvic Pain. She has presented lectures to students and colleagues on pelvic pain. Carmel was part of the Local Organising Committee for the 24th AMS Annual Congress, 2021 in Adelaide. She is passionate about assisting women manage any symptoms they may be experiencing in midlife and knows good menopause symptom management can be life changing.

Dr Sonia Davison MBBS FRACP PhD

Dr Davison is immediate Past-President of the AMS. Sonia is an Endocrinologist with a special interest in Women’s Health. She is a Clinical Fellow at Jean Hailes for Women’s Health and has an adjunct appointment at the Women’s Health Research Program, Monash University.

Sonia is in private practice in Victoria at Cabrini Medical Centre and at Jean Hailes for Women’s Health. Her PhD and postdoctoral research examined sex steroid physiology in women, including measurement of androgens and their relationships with age, mood, sexual function and cognition. 

Moderator

Dr Elina Safro
Chair, AMS Education Subcommittee and AMS Board Director

 Content updated 26 June 2023

About the Menopause: Case studies webcast

Note: The archive version is now availble on https://elearning.menopause.org.au/ 

AMS Members free access.

Other access to this course is $50 (GST INC) by payment through PayPal. (You do not require a PayPal account as the process accepts major credit cards.) 

===

This webinar is designed to be a practical and interactive guide on the management of complex menopause cases in General Practice. The session will be presented by Dr Carmel Reynolds, GP and Dr Sonia Davison, Endocrinologist who both have high level expertise in the management of menopause. Dr Elina Safro, Chair of the AMS Education Subcommittee will be moderating the session. Cases to be presented include patients with migraine, venous thromboembolism and breast cancer risk. Participants are also invited to submit their own cases for discussion. The session will be followed with 30-minutes of Q&A.

Speakers

Dr Carmel Reynolds MBBS, DCH FRACGP Cert Family Planning

Dr Reynolds is the SA/NT representative AMS Board Member. She is a GP with a strong interest in Women’s Health generally but specifically in contraception sexual health, menopause, and perinatal health. Carmel has worked in rural, regional and metropolitan practices in Western Australia and in inner city Adelaide.

Carmel is a member of the Adelaide Pelvic Pain Network, a multidisciplinary team developed to help care for people with persistent Pelvic Pain. She has presented lectures to students and colleagues on pelvic pain. Carmel was part of the Local Organising Committee for the 24th AMS Annual Congress, 2021 in Adelaide. She is passionate about assisting women manage any symptoms they may be experiencing in midlife and knows good menopause symptom management can be life changing.

Dr Sonia Davison MBBS FRACP PhD

Dr Davison is immediate Past-President of the AMS. Sonia is an Endocrinologist with a special interest in Women’s Health. She is a Clinical Fellow at Jean Hailes for Women’s Health and has an adjunct appointment at the Women’s Health Research Program, Monash University.

Sonia is in private practice in Victoria at Cabrini Medical Centre and at Jean Hailes for Women’s Health. Her PhD and postdoctoral research examined sex steroid physiology in women, including measurement of androgens and their relationships with age, mood, sexual function and cognition. 

Moderator

Dr Elina Safro
Chair, AMS Education Subcommittee and AMS Board Director

  Thank you to Besins for the unrestricted education grant that made this webinar possible.

 Content updated Auugust 2023

 Thank you to Besins for the unrestricted education grant that made this webinar possible.

About the Perimenopause webcast

The perimenopause is an important transitional stage of life. It can be associated with a variety of symptoms and potential health consequences. This webinar is targeted at GPs, endocrinologists, gynaecologists and other healthcare providers who wish to upskill their management of women in midlife.

In this webinar, Gynaecologist Professor Rod Baber and GP Dr Karen Magraith explore the clinical issues and management challenges that arise during perimenopause.

Karen discusses the dilemmas for GPs managing women in the perimenopause, including mental health issues and also how to approach the menopause consult.

Rod discusses the investigation and management of bleeding in the perimenopause, as well as the risks and benefits of menopausal hormone therapy.

Speakers

Dr Karen Magraith BMBS FRACGP

Karen Magraith is President of the AMS. She graduated from Flinders University and spent 6 years in Darwin before returning to Adelaide, where she worked until 2007. Karen currently works in general practice in Hobart, where she is involved in registrar training. She has had a longstanding interest in women’s health and has been a member of AMS since 2004. Karen recognises that most menopause medicine occurs in general practice, where the GP is in a unique position to manage the medical, gynaecological and psychosocial issues in an integrated way. Karen is keen to promote the role of the AMS in educating and supporting a wide variety of GPs, to enable them to provide high quality health care to women.

Clinical Professor Rod Baber AM

Clinical Professor of Obstetrics and Gynaecology at Sydney Medical School, University of Sydney, Professor Rod Baber is Past President of the International Menopause Society. He studied Pharmacy and then Medicine at the University of Sydney. He completed specialist training in Obstetrics and Gynaecology at Australia’s Royal North Shore Hospital and in the UK at Kings College Hospital and the Lister Fertility and Endocrinology Centre. Professor Baber holds a Fellowship of both the Royal and Royal Australian & New Zealand Colleges of Obstetricians and Gynaecologists. He holds specialist appointments at North Shore Private and the Mater Hospitals in Sydney, is a visiting medical officer at the Royal North Shore Hospital and has a practice specialising in gynaecology in St Leonards.

Moderator

Dr Elina Safro
Chair, AMS Education Subcommittee and AMS Board Director

 Content updated 7 April 2022

Join us online at 7.00pm on Thursday 21 March 2024 for the AMS Webinar: Vasomotor symptom (VMS) management with non-hormonal options. This webinar is targeted at GPs, specialists and allied health workers who are seeking a comprehensive update on non-hormonal therapies for VMS. Although menopausal hormone therapy (MHT) is the most effective option for management of VMS and genitourinary symptoms, some women are unable to use MHT, for personal or health reasons.

Dr Sonia Davison, Endocrinologist and AMS Past-President, will take us through evidence-based non-hormonal options for vasomotor symptoms, including a new therapy using a neurokinin 3 (NK3) receptor antagonist. AMS President Dr Sylvia Rosevear will chair the meeting and there will be plenty of time for questions.

Read more and register here

AMS Webinar: Menopause Case studies | 2 May 2023

This webinar is designed to be a practical and interactive guide on the management of complex menopause cases in General Practice. The session will be presented by Dr Carmel Reynolds, GP and Dr Sonia Davison, Endocrinologist who both have high level expertise in the management of menopause. Dr Elina Safro, Chair of the AMS Education Subcommittee will be moderating the session. Cases to be presented include patients with migraine, venous thromboembolism and breast cancer risk. Participants are also invited to submit their own cases for discussion. The session will be followed with 30-minutes of Q&A.

Read more and register here

AMS Webinar: Perimenopause | 5 April 2022

Missed the AMS Webinar?

The recording is now available here. 

The perimenopause is an important transitional stage of life. It can be associated with a variety of symptoms and potential health consequences. This webinar is targeted at GPs, endocrinologists, gynaecologists and other healthcare providers who wish to upskill their management of women in midlife.

In this webinar, Gynaecologist Professor Rod Baber and GP Dr Karen Magraith will explore the clinical issues and management challenges that arise during perimenopause.

AMS Webinar: What’s new - The use of testosterone in women | 24 March 2021

Missed the AMS Webinar?

The recording is now available here. 

This webinar is targeted at GPs, endocrinologists, gynaecologists, pharmacists and other healthcare professionals. This presentation will include a review of basic female androgen physiology, when it is appropriate to prescribe testosterone for women as well as how to prescribe testosterone for women. Case studies will be presented and there will be plenty of time for questions.

Content updated April 2023

The AMS Board is pleased to bring you this webinar recording on the use of testosterone therapy in women. This webinar is targeted at GPs, endocrinologists, gynaecologists, pharmacists and other healthcare professionals. This presentation will include a review of basic female androgen physiology, when it is appropriate to prescribe testosterone for women as well as how to prescribe testosterone for women. Case studies were presented, as well as questions answered.

Speaker

Professor Susan Davis, MBBS, FRACP, PhD, FAHMS, AO

Professor Davis is an NHMRC Senior Principal Research Fellow, Director, Monash University Women’s Health Research Program, Consultant Endocrinologist and Head, Specialist Women’s Health Clinic for women with complex disease, Alfred Hospital Melbourne and consultant at Cabrini Medical Centre.

Her research has advanced the understanding of estrogen and testosterone action, deficiency and replacement in women. She is a past president of the Australasian Menopause Society and immediate past President of the International Menopause Society. She has over 420 peer-reviewed publications and has numerous awards.

Her contributions to endocrinology were recognized by the International Menopause Society Distinguished Service Award (2020), Endocrine Society of Australia Life Membership Award (2020), Endocrine Society of Australia Senior Plenary Award (2019) and the International Excellence in Endocrinology Laureate Award of the Endocrine Society USA (2015).

Moderator

Dr Sonia Davison MBBS FRACP PhD

Dr Davison is the President of the AMS and was appointed to the AMS Board in February 2017.

She is an Endocrinologist with a special interest in Women’s Health. She is a Clinical Fellow at Jean Hailes for Women’s Health and has an adjunct appointment at the Women’s Health Research Program, Monash University.

She is in private practice in Victoria at Cabrini Medical Centre and at Jean Hailes for Women’s Health. Her PhD and postdoctoral research examined sex steroid physiology in women, including measurement of androgens and their relationships with age, mood, sexual function and cognition.

She was also editor of AMS’s Changes magazine for nine years.

Abstract

The role of testosterone in women and its potential as a therapeutic agent continues to attract controversy. The clinical trials of testosterone therapy for women have primarily focussed on treatment of female sexual dysfunction, with the largest placebo-controlled studies being of transdermal testosterone in postmenopausal women. Based on the cumulative data from these studies, loss of sexual desire with associated personal distress is presently the only agreed upon indication for judicious testosterone supplementation for postmenopausal women.

Based on the available data, testosterone supplementation should not be used to improve cardiometabolic, musculoskeletal or cognitive health, wellbeing and low mood, or vasomotor symptoms in postmenopausal women; there are presently insufficient data to support the use of testosterone in premenopausal women. Globally, the use of compounded testosterone formulations is discouraged, and when these are the only treatment option, adherence to the highest manufacturing standard is required. In Australia, a TGA approved testosterone is now available. Therefore this abrogates the need to prescribe compounded testosterone. Testosterone supplementation for women with HSDD should always be considered a trial of therapy.

Content created March 2021